Incyte reports tafasitamab combo benefit in Phase III frontMIND study
The trial compared Tafa-Len-R-CHOP to R-CHOP alone, the current standard of care, for efficacy and safety.
Clinical Trials
Lilly reports Phase III BRUIN CLL-322 trial results for Jaypirca combo
J&J reports data from Phase II/III ENERGY trial for wAIHA
Novo Nordisk identifies unauthorised data access from trials
MAIA Biotechnology opens second US site for THIO-101 trial
CONNECTA Therapeutics begins Phase IIa trial of CTH120 for FXS
Alpha Cognition announces top-line data in BEACON study for Alzheimer’s
Windward Bio doses first patients in Phase II SIRIUS COPD trial
